US Stocks
/
Aktis Oncology, Inc. Share Price
Aktis Oncology, Inc. Share Price

Aktis Oncology, Inc. Share Price

NASDAQ: AKTS
$18.17
+$0.39 (2.16%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aktis Oncology, Inc. Stock Performance

Open
$17.96
Prev. Close
$17.79
Circuit Range
N/A
Day Range
$17.65 - $18.16
Year Range
$14.72 - $34.06
Volume
12,160
Average Traded
$17.96

Aktis Oncology, Inc. Share Price Today

As of 11 October 2026, Aktis Oncology, Inc.'s share price is $18.17. The stock opened at $17.96, compared to its previous close of $17.79. During today's trading session, Aktis Oncology, Inc.'s share price traded between $17.65 and $18.16, with an average price of $17.91. Over the past 52 weeks, the stock has recorded a high of $34.06 and a low of $14.72. In terms of performance, Aktis Oncology, Inc.'s share price has declined by 3.09% over the last six months and is down 9.85% on a year-on-year basis.

Aktis Oncology, Inc. Share Price Chart

$17.65$18.16
L
Show Current Price
H

Aktis Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$27.38B
Return On Equity (TTM)
N/A
Profit Margin
-613.40%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
77.81%

Aktis Oncology, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Mar 2026Jun 2026
Revenue$5.86$9.03$3.23$3.38
Net Profit-$108.80-$6.42-$18.33-$24.14
Net Profit Margin-1856.66%-71.10%-567.49%-714.20%
Income ChangeN/A94.10%-185.51%-31.70%

Aktis Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars202220232024
Revenue$15.35$27.12$27.38
Net Profit-$59.03-$63.56-$167.95
Net Profit Margin-384.56%-234.37%-613.40%
Income ChangeN/A-7.67%-164.24%

About Aktis Oncology, Inc.

Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.

Aktis Oncology, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$18.91
$18.16
-6.80%
Sep 2026
$26.02
$19.48
-25.68%
Aug 2026
$21.68
$26.21
+18.81%
Jul 2026
$31.66
$22.06
-31.72%
Jun 2026
$20.24
$32.31
+55.67%
May 2026
$18.50
$20.75
+10.69%
Apr 2026
$18.54
$18.75
+4.57%
Mar 2026
$19.57
$17.93
-11.26%
Feb 2026
$20.00
$20.20
+0.25%
Jan 2026
$27.43
$20.16
N/A

AKTS Share Price FAQs

What is Aktis Oncology, Inc. share price today?

chevron-up
Aktis Oncology, Inc. share price today is $18.17 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Aktis Oncology, Inc. stock?

chevron-up
The 52 week high of Aktis Oncology, Inc. stock is $34.06, while the 52 week low is $14.72 as of 10 Oct '26.

What is AKTS's net income for the last quarter?

chevron-up
AKTS's net income for the last quarter is -24.14B USD.

What is the 5 year returns of AKTS?

chevron-up
The 5 year returns of AKTS is -9.85% as on 10 Oct '26.

What is the high & low stock price of AKTS today?

chevron-up
AKTS stock price hit a high of $18.16 and low of $17.65 as of 10 Oct '26.

Can I buy AKTS shares in India?

chevron-up
Yes. You can buy AKTS in India by opening an international trading account.